Emblation, the Scottish health tech firm focused on microwave treatments for skin conditions, is investing £4 million in a new headquarters for their employees, complete with manufacturing facilities.

The company is set to begin a phased move to the new offices in Stirling with over 60 existing employees set to gain access to the facilities.

Emblation recently announced a new round of trails in the US to expand the use of its Swift device, a portable microwave device used to treat skin conditions like warts and verrucae.

Currently, the device is being trialled as a potential treatment for life-threatening conditions like cervical and skin cancers.

The new facilities in Stirling will see manufacturing come in house, as well as providing employees with gym access, games facilities, and cycle paths.

Headcount of the company has more than doubled since its start 15 years ago, and the founders Gary Beale and Eamon McErlean are determined to stay in Scotland after meeting as post-graduates at Edinburgh’s Heriot-Watt University.

“In our sphere, America is the place to be, so it would have been the easiest thing in the world for us to set up our headquarters in the US,“ said Beale, referring to the US’s health device market, the largest in the world.

“However, we were determined to retain the strongest possible Scottish identity.

“We’ve worked really hard to create a space where we hope it will be inspiring, enjoyable and rewarding to come to work.”

The new 20,000 square foot building was supported in part by Scottish Enterprise Regional Assistance funding, and was designed by Keppie Designs, a Glasgow architecture firm, and Neil Porteous, a contractor based in Alloa.

Recommended

• Scot Health Tech Emblation Launches $2M Trial in USA
• Scots HealthTech Hits 100,000 Treatments in UK
• Scots Healthtech Device Shows Promise in Cervical Cancer Treatment

Since it was founded nearly 15 years ago, Emblation has expanded outside of the UK, creating Emblation US in an acquisition move and setting up new companies in Canada and Germany.

About 4,000 sq ft of the premises will be dedicated as a manufacturing area, bringing its production in house.

“Manufacturing is not a sector which has been faring well in the UK over recent years, so bringing production back to Scotland and centralising our production at Emblation House will have a significant impact in reducing our carbon footprint – something we are very proud of,” Beale said.